Subscribe
Pet Food & CPG
8 min read

Will Lisman | CEO, The Honest Kitchen

Honest Kitchen CEO Will Lisman on scaling the original human-grade pet food brand, why Clusters is the first real trade-up from kibble, the cost reality of premium pet nutrition, manufacturing as a moat, and why he's building for 50 years — not for an exit.

Written by
Roy Ben-Tzvi
Published on
October 27, 2026
Will Lisman, CEO of The Honest Kitchen

Will Lisman joined The Honest Kitchen as CEO in the fall of 2023 after nearly two decades in consumer products. Today, he is focused on scaling one of the original human-grade pet food brands amid an increasingly competitive category.

‍

You joined The Honest Kitchen in 2023. What drew you to the company?

I've spent my entire career in consumer products, going on two decades now. Earlier in my career, I had exposure to the pet category as a management consultant working with private equity firms investing in high-growth pet food businesses like Wellness and Nature's Variety. After that, I spent about 15 years on the human side of food and beverage, including nearly a decade at Hershey and then HumanCo, a health and wellness platform company.

The Honest Kitchen was really compelling because it was already a strong business with a tremendous track record and a pioneering position in the category, but it was also at an inflection point. There was still a lot of untapped potential, and the business needed to professionalize in order to scale. That combination made it a very exciting opportunity.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Pro
Keep Reading

Other Interviews

More conversations with founders, operators, and investors building the future of pet care.

Learn more
Deven Vespi | Advisor, DRV Advisory
Pet Health & Wellness
13 min read

Deven Vespi | Advisor, DRV Advisory

Clinically proven has no shared definition in pet, yet it now shapes deals as much as labels. Deven Vespi learned the trade in FDA-regulated animal health, and she explains how to check a study before you trust it or build a deal on it. She covers sample sizes, dosing gaps, why brands get blindsided by their own research, and how long published data stays an edge.

Learn more
Learn more
Meet the Founders: 3 Startups Shaping the Future of Pet Health
Pet Health & Wellness
10 min read

Meet the Founders: 3 Startups Shaping the Future of Pet Health

Pawsible Ventures took seven of more than 130 applicants into its second cohort. Three of them work very different corners of pet health. Nicole Shlomof and Gila Leibovitch of Pawp Water sell functional water to owners who already fill the bowl, Andria Beal of EpiPaws turned dolphin epigenetics research into biological-age tests for dogs and cats, and Elliot Greenwood of ChckVet sells software to vet practices that resist new tech.

Learn more
Learn more
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Pet Health & Wellness
17 min read

Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics

Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.

Learn more
View all interviews